Vinoi George David

Vinoi George David

Auto-generated profile, based on publicly available information

Vinoi George David

Department of Nephrology, Christian Medical College, Vellore, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
SKSanthosh E. Kumar
Santhosh E. Kumar
AGAshish Goel
Ashish Goel
UZUday Zachariah
Uday Zachariah
SNSukesh C. Nair
Sukesh C. Nair
VDVinoi G. David
Vinoi G. David
CEChundamannil Eapen Eapen
Chundamannil Eapen Eapen

12 November 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
LTLeenath Thomas
Leenath Thomas
JCJolly Chandran
Jolly Chandran
AGAshish Goel
Ashish Goel
EJEbor Jacob
Ebor Jacob
BCBinila Chacko
Binila Chacko
UZUday Zachariah
Uday Zachariah

7 November 2023 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
KSKunwar A. Singh
Kunwar A. Singh
SKSanthosh E. Kumar
Santhosh E. Kumar
UZUday G. Zachariah
Uday G. Zachariah
DDDolly Daniel
Dolly Daniel
VDVinoi David
Vinoi David
AGAshish Goel
Ashish Goel

14 March 2023 in Glomerular Diseases
Verified
Journal Article
Open access
PDF file
EJElenjickal Elias John
Elenjickal Elias John
SRSanjeet Roy
Sanjeet Roy
ADAnup J. Devasia
Anup J. Devasia
RKReka Karuppusami
Reka Karuppusami
NJNisha Jose
Nisha Jose
SASuceena Alexander
Suceena Alexander
Introduction: Post hematopoietic stem cell transplant (HSCT), kidney can be subjected to injury by various causes. Of these, graft versus host disease (GvHD) affecting the kidney is an under-recognized entity with no clear guidelines on its diagnosis, clinicopathological manifestations, and outcomes. Material and Methods: Out of 2,930 patients who underwent HSCT at our center between 2005 and 2020, kidney biopsy was performed in 19 allogenic and 5 autologous recipients. Results: The mean age of the cohort at transplant was 33.2 ± 7 years, and 15 (62%) were males. Median time to kidney biopsy from HSCT was 14 (IQR, 9–30) months. Aplastic anemia was the most common underlying hematological disease (54.2%). All 19 allogenic recipients were classified based on clinicopathological manifestations into either thrombotic microangiopathy (TMA, 12/19 [63%]) or nephrotic syndrome (NS, 7/19 [37%]) pattern. Glomerular tuft “mesangiolysis” was the dominant pattern of injury noted in 9/12 cases of TMA pattern. There was a predominance of acute microangiopathic changes restricted primarily to the glomerular compartment. Of the 7 patients with NS pattern, membranous nephropathy was seen in 4 (57%) and minimal change disease in 3 (43%) patients. Thirty-nine percent (7/18) stained positive for C4d which was predominantly glomerular. Allogenic recipients who did not receive immunosuppression (IS) for renal disease had a lower eGFR at biopsy, a longer latency between withdrawal of GvHD prophylaxis and biopsy, and were significantly at a higher risk of kidney failure (IS: 2/11, 18.1% vs. no IS: 2/6, 33.3%, p = 0.04). “Associated extra-renal GvHD” occurred in 11/19 (57.9%) allogenic recipients. Patients with “associated extra-renal GvHD” had significantly more deaths (6/11, 60% vs. 0, p = 0.02) but comparable renal outcomes. Conclusion: Renal GvHD can present with or without “associated extra-renal GvHD” after a prolonged period of withdrawal of GvHD prophylaxis, requiring careful diagnostic vigilance and consideration of IS.


11 October 2023 in Pancreatology
Verified
Journal Article
Closed access
SCSudipta Dhar Chowdhury
Sudipta Dhar Chowdhury
ATAjith Thomas
Ajith Thomas
RKReuben Thomas Kurien
Reuben Thomas Kurien
PGPiyush Gupta
Piyush Gupta
AJAnoop John
Anoop John
CEC.E. Eapen
C.E. Eapen